Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis

Eur Respir J. 2017 May 21;49(5):1700742. doi: 10.1183/13993003.00742-2017. Print 2017 May.

Ioana D Olaru^{1

2}, Jan Heyckendorf^{1

3}, Sönke Andres⁴, Barbara Kalsdorf^{1

3}, Christoph Lange^{5

3

6

7}

¹ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
² Dept of Microbiology, University Hospitals of Leicester, Leicester, UK.
³ German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany.
⁴ Division of Mycobacteriology (National Tuberculosis Reference Laboratory), Research Center Borstel, Borstel, Germany.
⁵ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany clange@fz-borstel.de.
⁶ Dept of Medicine, Karolinska Institute, Stockholm, Sweden.
⁷ Dept of Medicine, University of Namibia School of Medicine, Windhoek, Namibia.

No abstract available

Publication types